FDA Approves New Breast Cancer Drug That Fights Resistance

The FDA just approved a groundbreaking breast cancer treatment that specifically targets tumors that have stopped responding to standard therapy.

It's the first cancer drug guided by detecting resistance mutations in blood tests before scans show the disease has spread.